LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION

QR Code

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION

Classification, modes of action and clinical effects of calcium channel blockers are presented. Advantages of the third generation of dihydropyridine calcium channel blockers are considered. Clinical pharmacology, studies on the efficacy, safety and prevention of hypertensive complications with lerc...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	arterial hypertension antihypertensive therapy calcium antagonists lercanidipine
Online Access:	https://www.rpcardio.online/jour/article/view/77
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

Lercanidipine in arterial hypertension
by: C. Borghi
Published: (1970-01-01)

LERCANIDIPINE IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: C. Beckey, et al.
Published: (2009-08-01)

POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE
by: E. L. Trisvetova
Published: (2015-09-01)

Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers
by: K. Makarounas-Kirchmann, et al.
Published: (2010-12-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION TREATMENT: SPECIFICS OF LERCANIDIPINE
by: I. O. Minushkina
Published: (2015-02-01)

THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS
by: E. EL. Trisvetova
Published: (2015-09-01)

ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION
by: N. A. Dzhaiani
Published: (2015-09-01)

TREATMENT OF ESSENTIAL HYPERTENSION WITH CALCIUM CHANNEL BLOCKERS: WHAT IS THE PLACE OF LERCANIDIPINE
by: Michel Burnier, et al.
Published: (2010-04-01)

Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy
by: E. O. Taratukhin
Published: (2013-06-01)

ASSESSMENT OF COGNITIVE FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION TREATED WITH LERCANIDIPINE
by: J. Tisaire-Sánchez, et al.
Published: (2011-04-01)

A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
by: E. I. Emelina, et al.
Published: (2015-11-01)

NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION
by: O. D. Ostroumova, et al.
Published: (2016-01-01)

Treatment of proteinuria with lercanidipine associated with reninangiotensin axis-blocking drugs
by: N. R. Robles, et al.
Published: (2011-06-01)

Calcium regulation by calcium antagonists /
Published: (1982)

COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION
by: S. A. Boitsov, et al.
Published: (2016-01-01)

Lercanidipine in general practice settings: safety and effectiveness. The LAPSE Study results
by: N. R. Robles, et al.
Published: (2010-10-01)

Challenges in hypotensive therapy: the role of calcium antagonists
by: E. O. Taratukhin, et al.
Published: (2013-04-01)

EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: D. A. Yakhontov, et al.
Published: (2016-01-01)

Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study
by: V. Barrios, et al.
Published: (1970-01-01)

Lercanidipine in patients with chronic renal failure: the ZAFRA Study
by: N. R. Robles, et al.
Published: (2010-08-01)

COMBINATION THERAPY IN THE MANAGEMENT OF ARTERIAL HYPERTENSION: EFFECTIVENESS OF THE LERCANIDIPINE AND ENALAPRIL COMBINATION
by: L. O. Minushkina
Published: (2013-10-01)

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01)

FIXED ANTIHYPERTENSIVE DRUGS COMBINATION SELECTION WITH THE AIM OF ORGANS PROTECTION
by: O. D. Ostroumova, et al.
Published: (2015-05-01)

CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY
by: R. I. Striuk
Published: (2016-01-01)

PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION
by: D. S. Kaskaeva, et al.
Published: (2017-03-01)

RESULTS OF PHARMACOEPIDEMIOLOGIC STUDY OF ARTERIAL HYPERTENSION PIFAGOR IV: PHYSICIANS COMPLIANCE
by: M. V. Leonova, et al.
Published: (2015-01-01)

DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
by: A. A. Shadrin, et al.
Published: (2019-01-01)

Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine
by: O. V. Zimnitskaya, et al.
Published: (2016-11-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS AND THE TREATMENT OF ARTERIAL HYPERTENSION AND OBESITY PATIENTS IN ACCORDANCE WITH THE MODERN CLINICAL GUIDELINES
by: S. R. Gilyarevskyi, et al.
Published: (2014-04-01)

Antihypertension drugs in prevention of cognition disorder and dementia: focus on calcium channel blockers and diuretics
by: O. D. Ostroumova, et al.
Published: (2018-10-01)

Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
by: V. B. Mychka, et al.
Published: (2008-12-01)

Calcium antagonist effectiveness and tolerability in hypertensive men and women
by: A. E. Bragina, et al.
Published: (2006-08-01)

RESISTANT HYPERTENSION IN A PATIENT WITH METABOLIC SYNDROME
by: O. M. Drapkina, et al.
Published: (2017-01-01)

CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS
by: D. V. Nebieridze
Published: (2015-12-01)

STROKE PREVENTION OPPORTUNITIES FOR CARDIOLOGISTS: COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION (ROLE OF CALCIUM ANTAGONISTS)
by: E. O. Taratukhin
Published: (2013-08-01)

Blood Pressure and Metabolic Effect of a Combination of Lercanidipine with Different Antihypertensive Drugs in Clinical Practice
by: Arrigo F.G. Cicero, et al.
Published: (2012-02-01)